Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
Clinical trial NCT07425392 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07425392
- Sponsor
- Vaxcyte, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-09
- Primary completion
- 2027-03-01
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.